Moderna (MRNA) Shares Drop 8% despite Impressive Result from Cancer Vaccine Phase 2 Trial Submitted by Anonymous (not verified) on Tue, 04/18/2023 - 11:20 Coinspeaker
Moderna Gains 7% as Cowen Upgrades MRNA Stock from Market Perform to Outperform Submitted by Anonymous (not verified) on Tue, 03/14/2023 - 11:10 Coinspeaker
Moderna Sees X3 Covid Vaccine Sales in Q1 2022, MRNA Stock Jumps 7% Submitted by Anonymous (not verified) on Wed, 05/04/2022 - 18:00 Coinspeaker
Shares of Moderna, Pfizer, BioNTech Decline as New Cases of Omicron Variant Eases Submitted by Anonymous (not verified) on Tue, 02/15/2022 - 13:50 Coinspeaker
MRNA Shares Up 9% as Moderna Starts Working on Booster Targeting Omicron Variant Submitted by Anonymous (not verified) on Tue, 01/11/2022 - 11:30 Coinspeaker
MRNA Stock Up 10% in Pre-market, Moderna to Release Omicron Variant Vaccine Early Next Year Submitted by Anonymous (not verified) on Mon, 11/29/2021 - 12:20 Coinspeaker
MRNA Stock Up 3%, Moderna Resubmits Application for Vaccine Booster Shots for All Adults Submitted by Anonymous (not verified) on Thu, 11/18/2021 - 13:30 Coinspeaker
MRNA Stock Down 18%, Moderna Reports Lower-than-Expected Q3 2021 Earnings Submitted by Anonymous (not verified) on Fri, 11/05/2021 - 11:57 Coinspeaker
MRNA Stock Up Over 7%, Moderna Announces 2-in-1 Covid Vaccine Shot Submitted by Anonymous (not verified) on Fri, 09/10/2021 - 12:55 Coinspeaker
Vaccine Stocks Soar in Wake of Renewed Coronavirus Fears Submitted by Anonymous (not verified) on Tue, 08/10/2021 - 13:37 Coinspeaker